Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9U72
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,605
Award facts
- Contract value 100% obligated
- $60,604.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $60,604.66 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on January 5, 2026, with a completion date of January 6, 2026. The contract covers the supply of Cosentyx (secukinumab) Unoready 300 mg pen injections in 2 ml formulations, a biologic medication used for inflammatory and autoimmune conditions. This is a non-set-aside award issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The delivery order represents one of numerous pharmaceutical supply transactions AmerisourceBergen executes through its prime IDC vehicle, which serves as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen's federal procurement portfolio demonstrates consistent capability in fulfilling critical medical supply needs for the Defense Health Agency and other government healthcare entities across multiple therapeutic domains, positioning the company as a key vendor within DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F9U72?
SPE2DR26F9U72 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F9U72 worth?
The government has obligated $60,605 on SPE2DR26F9U72.
Is contract SPE2DR26F9U72 an order under another contract?
Yes. SPE2DR26F9U72 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9U72 competed?
The extent of competition for SPE2DR26F9U72 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award